ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.90
-0.22%
Dow Jones
40,954.48
1.85%
Gold vs US Dollar
2,469.12
1.94%
Brent Oil
83.315
-1.22%
Bitcoin
64,629.92
-0.34%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) News

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
28/07/201012:30Business WireAllos Therapeutics Reports Second Quarter 2010 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/07/201012:13Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/07/201012:00Business WireAllos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung CancerNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/07/201014:00Business WireAllos Therapeutics to Report Second Quarter 2010 Financial Results on July 28, 2010NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/07/201022:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/07/201022:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/06/201014:15Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/06/201023:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201014:00Business WireAllos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/06/201016:45Business WireAllos Therapeutics’ FOLOTYN Shows Activity & Tolerability in Phase 1 Dose Finding Study in Patients with Relapsed or Refrac...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/06/201014:00Business WireAllos Therapeutics Reports New Data Demonstrating that Responses to FOLOTYN are Correlated with Prolonged Survival in Patient...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/06/201014:00Business WireAllos Therapeutics to Present at Four Upcoming Investor ConferencesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/06/201014:14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/06/201014:00Business WireAllos Therapeutics Announces FOLOTYN® Data Presentations at the American Society of Clinical Oncology & the Congress of the ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/05/201014:00Business WireAllos Therapeutics to Present at the Citi Investment Research Global Health Care ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/05/201014:10Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/05/201013:52Dow Jones NewsAllos Gets Orphan-Drug Designation For Bladder Cancer DrugNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/05/201013:00Business WireAllos Therapeutics’ Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder CancerNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/05/201022:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201020:42Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/201021:10Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/201021:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/201021:00Business WireAllos Therapeutics Reports First Quarter 2010 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/05/201020:22Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

LSE
CU31
Ishr $ Gov 1-3a
LSE
VTY
Vistry
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved